1. Home
  2. OCUL vs PFLT Comparison

OCUL vs PFLT Comparison

Compare OCUL & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • PFLT
  • Stock Information
  • Founded
  • OCUL 2006
  • PFLT 2010
  • Country
  • OCUL United States
  • PFLT United States
  • Employees
  • OCUL N/A
  • PFLT N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • PFLT Finance: Consumer Services
  • Sector
  • OCUL Health Care
  • PFLT Finance
  • Exchange
  • OCUL Nasdaq
  • PFLT Nasdaq
  • Market Cap
  • OCUL 957.3M
  • PFLT 808.2M
  • IPO Year
  • OCUL 2014
  • PFLT N/A
  • Fundamental
  • Price
  • OCUL $8.01
  • PFLT $10.30
  • Analyst Decision
  • OCUL Strong Buy
  • PFLT Buy
  • Analyst Count
  • OCUL 10
  • PFLT 5
  • Target Price
  • OCUL $16.11
  • PFLT $11.20
  • AVG Volume (30 Days)
  • OCUL 1.8M
  • PFLT 925.6K
  • Earning Date
  • OCUL 05-05-2025
  • PFLT 05-12-2025
  • Dividend Yield
  • OCUL N/A
  • PFLT 11.94%
  • EPS Growth
  • OCUL N/A
  • PFLT N/A
  • EPS
  • OCUL N/A
  • PFLT 0.86
  • Revenue
  • OCUL $59,647,000.00
  • PFLT $232,975,000.00
  • Revenue This Year
  • OCUL N/A
  • PFLT $48.14
  • Revenue Next Year
  • OCUL $13.38
  • PFLT $9.03
  • P/E Ratio
  • OCUL N/A
  • PFLT $11.95
  • Revenue Growth
  • OCUL N/A
  • PFLT 49.56
  • 52 Week Low
  • OCUL $4.79
  • PFLT $8.82
  • 52 Week High
  • OCUL $11.78
  • PFLT $12.02
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 56.55
  • PFLT 55.63
  • Support Level
  • OCUL $6.86
  • PFLT $9.78
  • Resistance Level
  • OCUL $8.21
  • PFLT $10.38
  • Average True Range (ATR)
  • OCUL 0.48
  • PFLT 0.17
  • MACD
  • OCUL 0.08
  • PFLT 0.03
  • Stochastic Oscillator
  • OCUL 86.84
  • PFLT 86.67

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.

Share on Social Networks: